• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食欲素在帕金森病中的作用。

The role of orexin in Parkinson's disease.

机构信息

Health and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.

Discipline of Anatomy and Pathology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.

出版信息

J Neurosci Res. 2024 Mar;102(3):e25322. doi: 10.1002/jnr.25322.

DOI:10.1002/jnr.25322
PMID:38520160
Abstract

Emerging evidence has implicated the orexin system in non-motor pathogenesis of Parkinson's disease. It has also been suggested the orexin system is involved in the modulation of motor control, further implicating the orexin system in Parkinson's disease. Parkinson's disease is the second most common neurodegenerative disease with millions of people suffering worldwide with motor and non-motor symptoms, significantly affecting their quality of life. Treatments are based solely on symptomatic management and no cure currently exists. The orexin system has the potential to be a treatment target in Parkinson's disease, particularly in the non-motor stage. In this review, the most current evidence on the orexin system in Parkinson's disease and its potential role in motor and non-motor symptoms of the disease is summarized. This review begins with a brief overview of Parkinson's disease, animal models of the disease, and the orexin system. This leads into discussion of the possible roles of orexin neurons in Parkinson's disease and levels of orexin in the cerebral spinal fluid and plasma in Parkinson's disease and animal models of the disease. The role of orexin is then discussed in relation to symptoms of the disease including motor control, sleep, cognitive impairment, psychological behaviors, and the gastrointestinal system. The neuroprotective effects of orexin are also summarized in preclinical models of the disease.

摘要

越来越多的证据表明,食欲素系统与帕金森病的非运动发病机制有关。此外,食欲素系统还参与运动控制的调节,这进一步表明食欲素系统与帕金森病有关。帕金森病是第二常见的神经退行性疾病,全世界有数百万患者患有运动和非运动症状,严重影响了他们的生活质量。目前的治疗方法仅基于对症治疗,尚无治愈方法。食欲素系统有可能成为帕金森病的治疗靶点,特别是在非运动阶段。在这篇综述中,总结了关于帕金森病中食欲素系统的最新证据及其在运动和非运动症状中的潜在作用。这篇综述首先简要概述了帕金森病、疾病的动物模型和食欲素系统。接着讨论了食欲素神经元在帕金森病中的可能作用,以及帕金森病患者和动物模型的脑脊液和血浆中的食欲素水平。然后讨论了食欲素在运动控制、睡眠、认知障碍、心理行为和胃肠道系统等疾病症状中的作用。最后还总结了食欲素在疾病的临床前模型中的神经保护作用。

相似文献

1
The role of orexin in Parkinson's disease.食欲素在帕金森病中的作用。
J Neurosci Res. 2024 Mar;102(3):e25322. doi: 10.1002/jnr.25322.
2
Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential.食欲素与帕金森病:具有治疗潜力的保护性神经肽。
Neurochem Int. 2020 Sep;138:104754. doi: 10.1016/j.neuint.2020.104754. Epub 2020 May 15.
3
Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients.血浆食欲素-A 浓度升高与帕金森病患者的非运动症状有关。
Neurosci Lett. 2021 Jan 10;741:135480. doi: 10.1016/j.neulet.2020.135480. Epub 2020 Nov 5.
4
Orexin pathway in Parkinson's disease: a review.帕金森病中的食欲素通路:综述。
Mol Biol Rep. 2023 Jul;50(7):6107-6120. doi: 10.1007/s11033-023-08459-5. Epub 2023 May 8.
5
Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson's Disease.抑制食欲素/下丘脑分泌素神经元可改善 A53T 帕金森病小鼠模型的过度体力活动和能量消耗。
Int J Mol Sci. 2021 Jan 14;22(2):795. doi: 10.3390/ijms22020795.
6
Exploring the Role of Orexinergic Neurons in Parkinson's Disease.探索食欲素能神经元在帕金森病中的作用。
Neurotox Res. 2021 Dec;39(6):2141-2153. doi: 10.1007/s12640-021-00411-4. Epub 2021 Sep 8.
7
Orexins role in neurodegenerative diseases: From pathogenesis to treatment.食欲素在神经退行性疾病中的作用:从发病机制到治疗。
Pharmacol Biochem Behav. 2020 Jul;194:172929. doi: 10.1016/j.pbb.2020.172929. Epub 2020 Apr 18.
8
Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity.阿兹海默症相关基因 A53T 突变帕金森病模型的早期社交能力和社交记忆损伤可被化学遗传学调控食欲素神经元活性所改善。
Mol Neurobiol. 2019 Dec;56(12):8435-8450. doi: 10.1007/s12035-019-01682-x. Epub 2019 Jun 27.
9
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review.食欲素与α-突触核蛋白病中的睡眠障碍:系统综述。
Curr Neurol Neurosci Rep. 2024 Sep;24(9):389-412. doi: 10.1007/s11910-024-01359-6. Epub 2024 Jul 20.
10
Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.药物和化学遗传学调控食欲素/下丘脑分泌素干预可改善 A53T 帕金森病小鼠模型中海马依赖性记忆障碍。
Mol Brain. 2019 Oct 30;12(1):87. doi: 10.1186/s13041-019-0514-8.

引用本文的文献

1
Vital nutrition: enhancing health in advanced Parkinson's disease with device-aided therapies.重要营养:通过设备辅助疗法改善晚期帕金森病患者的健康状况
J Neural Transm (Vienna). 2025 Apr 24. doi: 10.1007/s00702-025-02935-x.
2
Cardiovascular Dysautonomia in Patients with Parkinson's Disease and Hypertension: A Cross-Sectional Pilot Study.帕金森病合并高血压患者的心血管自主神经功能障碍:一项横断面试点研究。
J Clin Med. 2025 Mar 25;14(7):2225. doi: 10.3390/jcm14072225.